Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients

Labetalol- and nicardipine-continuous infusions were comparable in the studied safety and efficacy outcomes including time at goal and BP variability. Further prospective studies are needed to validate these safety and efficacy findings and to assess clinical outcomes.